Skip to main content

Day: October 16, 2025

HCW Biologics to Participate in the 2025 Maxim Growth Summit

MIRAMAR, Fla., Oct. 16, 2025 (GLOBE NEWSWIRE) — HCW Biologics Inc. (the “Company”) (NASDAQ: HCWB), a U.S.-based clinical-stage biopharmaceutical company focused on discovering and developing innovative immunotherapies to extend healthspan by targeting the link between chronic inflammation and disease, is pleased to announce its participation in the upcoming 2025 Maxim Growth Summit, taking place from October 22nd to 23rd at The Hard Rock Hotel NYC. This prestigious event brings together industry leaders, innovators, and premier institutions to explore the latest trends and advancements across several industries. Dr. Hing C. Wong, the Company’s Founder and Chief Executive Officer, will be meeting with institutional investors in a one-on-one format, and senior Maxim analysts during the event. Keynote speakers include Larry Kudlow...

Continue reading

Edible Garden to Highlight USDA Organic Hydroponic Basil at the 2025 Global Produce & Floral Show, Booth #1856, October 16–18 at the Anaheim Convention Center in Anaheim, California

2025 Global Produce & Floral Show, Booth #18562025 Global Produce & Floral Show, Booth #18562025 Global Produce & Floral Show, Booth #1856 BELVIDERE, NJ, Oct. 16, 2025 (GLOBE NEWSWIRE) — Edible Garden AG Incorporated (“Edible Garden” or the “Company”) (Nasdaq: EDBL, EDBLW), a leader in controlled environment agriculture (CEA), locally grown, organic, sustainable produce and products, invites attendees of the 2025 Global Produce & Floral Show at the Anaheim Convention Center, October 16–18, to experience the future of fresh herbs at Booth #1856. “Edible Garden’s presence at the Global Produce & Floral Show underscores our growing leadership in controlled environment agriculture and our commitment to advancing technologies that minimize waste and maximize freshness on a global scale,” said Jim Kras,...

Continue reading

Farmers & Merchants Bancorp (FMCB) Reports Record Third Quarter 2025 Earnings

Third Quarter 2025 HighlightsNet income of $23.7 million, an increase of $1.6 million or 7.22% compared to the third quarter of 2024; Basic earnings per share of $34.24 and diluted earnings per share of $33.92; diluted earnings per share up 13.22% compared to the third quarter of 2024; Diluted earnings per share of $130.83 over the trailing twelve months, up 10.4% compared to $118.46 over the same trailing period a year ago and up 14.6% compared to $114.13 for the same period two years ago; Tangible book value per share increased 9.8% to $877.13 compared to $799.04 as of September 30, 2024; Achieved a return on average assets of 1.70% and a return on average equity of 15.10%; Net interest income of $55.4 million, up $3.4 million or 6.6% compared to $52.0 million in the third quarter of 2024; net interest margin (tax equivalent basis)...

Continue reading

VOLUNTARY DELISTING FROM NASDAQ FIRST NORTH GROWTH MARKET DENMARK

HRC WORLD PLC NASDAQ FIRST NORTH, COPENHAGENTICKER: HRCISIN: GB00BZ3CDY20 16 October 2025 VOLUNTARY DELISTING FROM NASDAQ FIRST NORTH GROWTH MARKET DENMARK This disclosure contains information that HRC World PLC is obliged to make public pursuant to the EU Market Abuse Regulation (EU nr 596/2014). HRC World Plc (“HRC World” or the “Company”) hereby announces that Nasdaq Copenhagen A/S has approved the Company’s request for the delisting of its shares from trading on Nasdaq First North Growth Market Denmark. The last day of trading in HRC World Plc shares on Nasdaq First North Growth Market Denmark will be 31 October 2025. Following that date, the Company’s shares will no longer be traded on the exchange. As informed in previous announcement, the Company is transitioning trading of its ordinary shares fully to the Aquis Stock Exchange...

Continue reading

Edible Garden Enters into Warrant Exercise Transaction for $4.2 Million in Gross Proceeds

BELVIDERE, NJ, Oct. 16, 2025 (GLOBE NEWSWIRE) — Edible Garden AG Incorporated (“Edible Garden” or the “Company”) (Nasdaq: EDBL, EDBLW), a leader in controlled environment agriculture (CEA), locally grown, organic, and sustainable produce and products, today announces that it has entered into a warrant exercise agreement with an accredited investor to exercise certain outstanding warrants held by the accredited investor to purchase an aggregate of 2,021,571 shares of common stock of the Company (the “Existing Warrants”). In consideration for the immediate exercise of the Existing Warrants for cash, the exercising holder received new unregistered warrants to purchase an aggregate of 4,043,142 shares of common stock (the “New Warrants”). In connection with the exercise, the Company also agreed to reduce the exercise price of such...

Continue reading

HCW Biologics’ Scientists to Present Three Posters During the 40th Annual Meeting of the Society for Immunotherapy of Cancer

Company poster presentations will debut research data of three lead drug candidates constructed with Company’s novel TRBC platform technology MIRAMAR, Fla., Oct. 16, 2025 (GLOBE NEWSWIRE) — HCW Biologics Inc. (“HCWB” or the “Company”) (NASDAQ: HCWB), a U.S.-based clinical-stage biopharmaceutical company focused on discovering and developing innovative immunotherapies to extend healthspan by targeting the link between chronic inflammation and disease, will present three posters to showcase the results of the IND enabling studies of the Company’s lead drug candidates based on its novel proprietary TRBC platform technology, at the upcoming 40th Annual Meeting of the Society for Immunotherapy of Cancer, taking place from November 5 to 9, 2025 in National Harbor, Maryland. The Company’s T-Cell Receptor β-Chain Constant Region platform...

Continue reading

Q/C Technologies Appoints Technion Professor Dr. Steven Frankel as Senior Quantum Advisor to Advance Photonic and Quantum-Class Computing Initiatives

Dr. Frankel brings extensive knowledge and deep expertise that bridges advanced physics and quantum technologies New York, NY, Oct. 16, 2025 (GLOBE NEWSWIRE) — Q/C Technologies, Inc. (Nasdaq: QCLS) (“Q/C” or the “Company”), a pioneer of quantum-class computing at the speed of light, today announced the appointment of Steven Frankel, Ph.D. as Senior Quantum Advisor. Dr. Frankel will help guide the Company’s ongoing efforts in quantum-class photonic computing to advance the development and commercialization of Q/C’s innovative Laser Processing Unit (LPU). Developed by LightSolver, Q/C’s LPU is the world’s first light and laser-based computing system designed to solve complex optimization and combinatorial problems at the speed of light. Dr. Frankel is currently the Rosenblatt Professor of Mechanical Engineering at the Technion –...

Continue reading

Exzeo Group, Inc. Launches Initial Public Offering

TAMPA, Fla., Oct. 16, 2025 (GLOBE NEWSWIRE) — HCI Group, Inc. (NYSE:HCI) today announced that its majority owned subsidiary, Exzeo Group, Inc., has launched its initial public offering (“IPO”) pursuant to a registration statement on Form S-1 filed with the U.S. Securities and Exchange Commission (the “SEC”). Exzeo is offering 8,000,000 shares of its common stock in the IPO. All shares being offered are primary shares, and HCI Group will retain majority ownership following the IPO. Exzeo intends to grant the underwriters a 30-day option to purchase up to an additional 1,200,000 common shares at the IPO price, less underwriting discounts and commissions. The IPO price is currently expected to be between $20.00 and $22.00 per share. Exzeo has applied to list its common stock on the New York Stock Exchange under the ticker...

Continue reading

Clean Energy Technologies, Inc. Advances Vermont Renewable Gas Project to Deliver Clean Power from Agricultural

Irvine, California, Oct. 16, 2025 (GLOBE NEWSWIRE) — Clean Energy Technologies, Inc. (Nasdaq: CETY) (the “Company” or “CETY”), a clean energy technology company delivering scalable solutions and technologies in waste-to-energy, power generation, storage, and heat-to-power, announced that the Vermont Public Utility Commission (PUC) has issued an order advancing the Vermont Renewable Gas – Lyndon (VRG-Lyndon) facility into the scheduling and public hearing stages of its Certificate of Public Good (CPG) permitting process. On October 1, 2025, the PUC formally authorized the start of its final permitting review for the proposed 2.2 MW agricultural waste-to-energy project located in Lyndon, Vermont. The VRG-Lyndon facility is being developed by Vermont Renewable Gas, LLC, an affiliate of CETY Capital, and represents a key milestone...

Continue reading

Autonomix Medical, Inc. to Highlight Innovative Nerve-Sensing and Ablation Platform at the 2025 Maxim Growth Summit

THE WOODLANDS, TX, Oct. 16, 2025 (GLOBE NEWSWIRE) — Autonomix Medical, Inc. (NASDAQ: AMIX) (“Autonomix” or the “Company”), a medical device company dedicated to advancing precision nerve-targeted treatments, today announced it will participate at the 2025 Maxim Growth Summit, taking place October 22-23, 2025 in New York, NY. This prestigious event brings together industry leaders, innovators, and premier institutions to explore the latest trends and advancements across several industries. As part of the conference, members of management will be available to participate in in-person one-on-one meetings with qualified members of the investor community who are registered to attend the conference. For more information and a complete agenda of the Maxim Growth Summit, please visit www.maximgrp.com/2025-growth-summit. About Maxim Group  Maxim...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.